Catalyst Calendar

Chronological list of catalyst events. Click on a ticker to view the company profile, click a drug to view prior data. Use the search box below to filter the catalyst results.

Drug | Disease (links)

Date | Stage

Volatility

RYTM

Late-4Q 2019 / early-1Q 2020

Setmelanotide

Leptin Receptor Deficiency Obesity

NDA Filing

Amp Volatility Score:

32%

BHVN

4Q 2019 / early-1Q 2020

Rimegepant

Migraine - preventative

Phase 3

Amp Volatility Score:

40%

KURA

Late-2019 / early 2020

KO-947

Solid tumors

Phase 1

Amp Volatility Score:

24%

RYTM

Late 4Q 2019 / early 1Q 2020

Setmelanotide

POMC deficiency obesity

NDA Filing

Amp Volatility Score:

32%

TGTX

Late 2019 / Early 2020

TG-1101 and TGR-1202

Chronic Lymphocytic Leukemia (CLL) and non-Hodgkin's Lymphoma (NHL)

Phase 3

Amp Volatility Score:

42%

LXRX

Early 2020

Sotagliflozin

Type 2 Diabetes

Phase 3

Amp Volatility Score:

48%

ZEAL

Early 2020

Dasiglucagon

Severe hypoglycemia in diabetes - children

NDA Filing

Amp Volatility Score:

N/A

KPTI

Early-2020

Selinexor

Multiple myeloma (Penta-Refractory)

Approved/Conditionally

Amp Volatility Score:

37%

CYTK

1/6/2020

CK-274

Hypertrophic Cardiomyopathies

Phase 2

Amp Volatility Score:

44%

BPMC

1/8/2020

Pralsetinib: RET

1L RET Fusion-positive non-small cell lung cancer (NSCLC)

Phase 1/2

Amp Volatility Score:

21%

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

PROUDLY CREATED WITH WIX.COM

  • Twitter Social Icon
  • LinkedIn Social Icon